SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6 POS - Post-effective amendments for immediately effective filing:
SEC Accession No. 0001193805-13-000938
Filing Date
2013-05-13
Accepted
2013-05-13 16:30:45
Documents
3
Effectiveness Date
2013-05-13

Document Format Files

Seq Description Document Type Size
1 e610905_f6pos-astellas.htm F-6 POS 105356
2 e610905_ex99-a.htm EX-99.(A) 76347
3 e610905_ex99-e.htm EX-99.(E) 8763
  Complete submission text file 0001193805-13-000938.txt   191853
Mailing Address 60 WALL STREET NEW YORK NY 10005
Business Address 60 WALL STREET NEW YORK NY 10005 212-250-9100
Astellas Pharma Inc (Subject) CIK: 0001446390 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: F-6 POS | Act: 33 | File No.: 333-154756 | Film No.: 13837740

Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

IRS No.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6 POS